Annual Report 2026
Filed with HKEX · Stock code 1406 · · 165 pages · English
Summary by 6ix AI
The report indicates a slight decline in revenue compared to the previous year, alongside a significant loss attributed to non-recurring costs related to governance issues and litigation. Despite these challenges, the company has shown signs of recovery, with revenue growth returning in the fourth quarter and a positive outlook for the upcoming financial year. The CEO's statement emphasizes the importance of governance and the company's commitment to enhancing its operational efficiency and market position.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Clarity Medical Group Holding Limited on 6ix
Earlier from Clarity Medical
- Interim report 2025/2026
- Annual Report 2025
- Supplemental announcement in relation to the appointment of executive director
- Appointment of executive director
- Interim results for the six months ended 30 September 2025
Later from Clarity Medical
- Notification of Publication of Corporate Communication and Change Request Form to Registered Shareholders
- Notification of Publication of Corporate Communication and Request Form to Non-Registered Shareholders
- Nomination Committee Terms of Reference
- List of Directors and their Roles and Functions
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Follow Clarity Medical into a list and get an email when it puts out news.
Follow Clarity Medical